203 related articles for article (PubMed ID: 35164157)
21. Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids.
Türe A; Ergül M; Ergül M; Altun A; Küçükgüzel İ
Mol Divers; 2021 May; 25(2):1025-1050. PubMed ID: 32328961
[TBL] [Abstract][Full Text] [Related]
22. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
[TBL] [Abstract][Full Text] [Related]
23. Induction of Cyp450 enzymes by 4-thiazolidinone-based derivatives in 3T3-L1 cells in vitro.
Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Rybczyńska-Tkaczyk K; Lesyk R; Gmiński J
Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):915-927. PubMed ID: 33219472
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of novel 4-thiazolidinone derivatives with promising anti-breast cancer activity: Synthesis, characterization, in vitro and in vivo results.
Tahmasvand R; Bayat P; Vahdaniparast SM; Dehghani S; Kooshafar Z; Khaleghi S; Almasirad A; Salimi M
Bioorg Chem; 2020 Nov; 104():104276. PubMed ID: 32992280
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, anticancer, and antibacterial activities of piplartine derivatives on cell cycle regulation and growth inhibition.
Kumar JU; Shankaraiah G; Kumar RS; Pitke VV; Rao GT; Poornima B; Babu KS; Sreedhar AS
J Asian Nat Prod Res; 2013; 15(6):658-69. PubMed ID: 23668860
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, Characterization, Anticancer and Antibacterial Activity of Some Novel Pyrano[2,3-d]pyrimidinone Carbonitrile Derivatives.
Aremu OS; Gopaul K; Kadam P; Singh M; Mocktar C; Singh P; Koorbanally NA
Anticancer Agents Med Chem; 2017; 17(5):719-725. PubMed ID: 27528181
[TBL] [Abstract][Full Text] [Related]
27. Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.
de Siqueira LRP; de Moraes Gomes PAT; de Lima Ferreira LP; de Melo Rêgo MJB; Leite ACL
Eur J Med Chem; 2019 May; 170():237-260. PubMed ID: 30904782
[TBL] [Abstract][Full Text] [Related]
28. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
29. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
30. Anticancer activity of 5-benzylidene-2-phenylimino-1, 3-thiazolidin-4-one (BPT) analogs.
Wu S; Guo W; Teraishi F; Pang J; Kaluarachchi K; Zhang L; Davis J; Dong F; Yan B; Fang B
Med Chem; 2006 Nov; 2(6):597-605. PubMed ID: 17105441
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Biological Evaluation of Structurally Diverse Benzimidazole Scaffolds as Potential Chemotherapeutic Agents.
Barasa L; Vemana HP; Surubhotla N; Ha SS; Kong J; Yong A; Croft JL; Dukhande VV; Yoganathan S
Anticancer Agents Med Chem; 2020; 20(3):301-314. PubMed ID: 31746304
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835
[TBL] [Abstract][Full Text] [Related]
33. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
34. Biologically active 4-thiazolidinones: a review of QSAR studies and QSAR modeling of antitumor activity.
Devinyak O; Zimenkovsky B; Lesyk R
Curr Top Med Chem; 2012; 12(24):2763-84. PubMed ID: 23368102
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel 2-imino-4-thiazolidinone derivatives as potent anti-cancer agents.
Appalanaidu K; Kotcherlakota R; Dadmal TL; Bollu VS; Kumbhare RM; Patra CR
Bioorg Med Chem Lett; 2016 Nov; 26(21):5361-5368. PubMed ID: 27546293
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of thiazolidinone-pyrazole conjugates as anticancer and antimicrobial agents.
Bhat M; Poojary B; Kalal BS; Gurubasavaraja Swamy PM; Kabilan S; Kumar V; Shruthi N; Alias Anand SA; Pai VR
Future Med Chem; 2018 May; 10(9):1017-1036. PubMed ID: 29708431
[TBL] [Abstract][Full Text] [Related]
38. Antiproliferative and tumor inhibitory studies of 2,3 disubstituted 4-thiazolidinone derivatives.
Sharath Kumar KS; Hanumappa A; Vetrivel M; Hegde M; Girish YR; Byregowda TR; Rao S; Raghavan SC; Rangappa KS
Bioorg Med Chem Lett; 2015 Sep; 25(17):3616-20. PubMed ID: 26152430
[TBL] [Abstract][Full Text] [Related]
39. 4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design.
Roszczenko P; Holota S; Szewczyk OK; Dudchak R; Bielawski K; Bielawska A; Lesyk R
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361924
[TBL] [Abstract][Full Text] [Related]
40. Utility of L-norephedrine in the semisynthesis of novel thiourea and thiazolidine derivatives as a new class of anticancer agents.
Ghorab MM; Alqasoumi SI; Abdel-Kader MS; Alsaid MS
Acta Pol Pharm; 2014; 71(4):615-23. PubMed ID: 25272887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
